- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 9, 2025 | 57.15M sh |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $96.18M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $85.99M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $100.94M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $88.18M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $94.03M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $102.57M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $115.73M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $122.64M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $35.07M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $39.45M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 54.35M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 54.29M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $1.21M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$16.88M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $35.86M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $29.15M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2023 | $31.47M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.11 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.21 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.21 |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $10.02M |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $25.5M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$5.93M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$11.26M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$5.66M |
| Operating Income restated | Q3 2025 · Mar 31, 2024 | −$10.45M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $6.12M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $19.22M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $23.89M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $95.35M |
| Revenue | Q3 2025 · Mar 31, 2024 | $30.02M |
| Revenue | Q3 2025 · Mar 31, 2024 | $114.57M |